Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

H. Keipp Talbot, MD MPH FIDSA

Professor
Vanderbilt University Medical Center

H. Keipp B. Talbot, MD, MPH, FIDSA is a Professor of Medicine and Health Policy within the Division of Infectious Diseases at Vanderbilt University Medical Center. She also holds the Vaccinology Research Directorship. As a dual appointee in Medicine and Health Policy, Dr. Talbot has played a pivotal role in the evaluation of viral respiratory diseases in adults and the evaluation of new and existing vaccines in older adults to improve immunization policy and vaccine development. Her goal is to continue to evaluate the use and effectiveness of vaccines, with a focus on prevention of infection and morbidity in adults. Dr. Talbot began her career by investigating the presentation of influenza in hospitalized adults. Her recent work has contributed to our understanding of the epidemiology of SARS-CoV-2, influenza, and respiratory syncytial virus. Dr. Talbot completed her tenure as Chair of the Advisory Committee on Immunization Practices (ACIP) in June 2025. During her 7 years on ACIP, she also served as the chair of the ACIP’s Influenza Vaccine Work Group and co-chair of the COVID-19 Vaccine Safety Technical Work Group. She has authored more than 280 manuscripts. Her work has informed national policy on the implementation of enhanced influenza vaccines for older adults, the use of pneumococcal vaccines in the setting of changing epidemiology, and COVID-19 vaccine introduction and use. Dr. Talbot currently co-leads the Tennessee Emerging Infections Program at Vanderbilt, which works to better understand viral respiratory disease epidemiology and inform vaccine policy.

Disclosure(s): No financial relationships to disclose.

Presentation(s):